Sunshine Biopharma Inc (SBFM)

Currency in USD
2.5425
-0.0575(-2.21%)
Real-time Data·
Trading near 52-week Low
SBFM is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.51002.5900
52 wk Range
2.5100464.0000
Key Statistics
Prev. Close
2.6
Open
2.59
Day's Range
2.51-2.59
52 wk Range
2.51-464
Volume
23.69K
Average Volume (3m)
296.75K
1-Year Change
-99.1691%
Book Value / Share
147.65
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBFM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1,120.0000
Upside
+43,951.13%
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Sunshine Biopharma Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1,120.0000
(+43,951.13% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Aegis Capital
Buy6.00+135.99%7.00MaintainNov 18, 2025

Earnings

Latest Release
Nov 12, 2026
EPS / Forecast
-5.20 / -4.00
Revenue / Forecast
9.44M / 9.1M
EPS Revisions
Last 90 days

SBFM Income Statement

Compare SBFM to Peers and Sector

Metrics to compare
SBFM
Peers
Sector
Relationship
P/E Ratio
−0.1x−3.3x−0.2x
PEG Ratio
0.00−0.020.00
Price/Book
0.0x3.0x2.6x
Price / LTM Sales
0.0x7.5x2.7x
Upside (Analyst Target)
-147.4%66.0%
Fair Value Upside
Unlock−6.7%10.8%Unlock

Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.

Employees
50

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
104.62K53.97%272.02K
Public Companies & Retail Investors
89.25K46.03%232.04K
Total
193.87K100.00%504.05K

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BJI Financial Group23.47%45,495118
Heights Capital Management, Inc.23.45%45,455118

People Also Watch

3.400
GRML
-2.86%
0.991
WFF
-7.39%
2.015
GLND
+1.26%
1.198
DKI
-2.57%
4.260
OMH
+7.04%

FAQ

What Is the Sunshine Biopharma (SBFM) Stock Price Today?

The Sunshine Biopharma stock price today is 2.5425 USD.

What Stock Exchange Does Sunshine Biopharma Trade On?

Sunshine Biopharma is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Sunshine Biopharma?

The stock symbol for Sunshine Biopharma is "SBFM."

What Is the Sunshine Biopharma Market Cap?

As of today, Sunshine Biopharma market cap is 492.9000K USD.

What Is Sunshine Biopharma's Earnings Per Share (TTM)?

The Sunshine Biopharma EPS (TTM) is -51.23.

When Is the Next Sunshine Biopharma Earnings Date?

Sunshine Biopharma will release its next earnings report on Mar 03, 2027.

From a Technical Analysis Perspective, Is SBFM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Sunshine Biopharma Stock Split?

Sunshine Biopharma has split 7 times.

How Many Employees Does Sunshine Biopharma Have?

Sunshine Biopharma has 50 employees.

What is the current trading status of Sunshine Biopharma (SBFM)?

As of Nov 17, 2026, Sunshine Biopharma (SBFM) is trading at a price of 2.5425 USD, with a previous close of 2.6000 USD. The stock has fluctuated within a day range of 2.5100 USD to 2.5900 USD, while its 52-week range spans from 2.5100 USD to 464.0000 USD.

What Is Sunshine Biopharma (SBFM) Price Target According to Analysts?

The average 12-month price target for Sunshine Biopharma is 1,120.0000 USD, with a high estimate of 1120 USD and a low estimate of 1120 USD. 1 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +43,951.13% Upside potential.

What Is the SBFM Premarket Price?

SBFM's last pre-market stock price is 2.5974 USD. The pre-market share volume is 1,150.0000, and the stock has decreased by -0.0026, or -0.1000%.

What Is the SBFM After Hours Price?

SBFM's last after hours stock price is 2.6600 USD, the stock has decreased by 0.0600, or 2.3100%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.